Should β blockers be second line treatment?BMJ 2010; 340 doi: http://dx.doi.org/10.1136/bmj.c1065 (Published 23 February 2010) Cite this as: BMJ 2010;340:c1065
- Jamal N Khan, specialist registrar in cardiology1,
- Abhishek Chauhan
- 1Sandwell and West Birmingham Hospitals NHS Trust, Birmingham B18 7QH
Boger-Megiddo and colleagues’ article implies that β blockers are a better second line agent for management of hypertension than calcium channel blockers,1 but we disagree.
After myocardial infarction, β blockade, but not calcium channel blockade, confers prognostic benefit through reduction in infarct size, risk of reinfarction, and mortality.2 …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial